Graduate Student Ethan Kub will be a Assistant MIDD member for Fall 2021. His application was selected by MIDD members based on scientific merit and potential to accelerate the progress to establish new and efficient therapeutics for glioblastoma. Ethan is currently in his third year of graduate research in the research group of Dr. Mirza. His research will be focused on the quantification of  ceramide and sphingosine-1-phosphate in vitro and in vivo, identification of metabolic products of lead compound ARN14988 and MS imagining of of ceramides in the brain.